Related references
Note: Only part of the references are listed.Frequentist and Bayesian Pharmacometric-Based Approaches To Facilitate Critically Needed New Antibiotic Development: Overcoming Lies, Damn Lies, and Statistics
Paul G. Ambrose et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
High-Level Cefixime- and Ceftriaxone-Resistant Neisseria gonorrhoeae in France: Novel penA Mosaic Allele in a Successful International Clone Causes Treatment Failure
Magnus Unemo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Population Pharmacokinetics of Metronidazole Evaluated Using Scavenged Samples from Preterm Infants
Michael Cohen-Wolkowiez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Meeting the Challenges of an Emerging Pathogen: The Henry Schueler 41&9 Foundation International Forum on Mucormycosis
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2012)
Imbalanced Mortality Evidence for Tigecycline: 2011, the Year of the Meta-analysis
Pablo E. Verde et al.
CLINICAL INFECTIOUS DISEASES (2012)
Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study
Richard G. Wunderink et al.
CLINICAL INFECTIOUS DISEASES (2012)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Phenotypic and genotypic properties of isolates in Norway in 2009: antimicrobial resistance warrants an immediate change in national management guidelines
S. O. Hjelmevoll et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
PHARMACOKINETICS OF MOXIFLOXACIN IN AN INFANT WITH MYCOPLASMA HOMINIS MENINGITIS
Kevin M. Watt et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Pharmacokinetics and Tolerability of Single-Dose Daptomycin in Young Infants
Michael Cohen-Wolkowiez et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Population Pharmacokinetics of Piperacillin Using Scavenged Samples From Preterm Infants
Michael Cohen-Wolkowiez et al.
THERAPEUTIC DRUG MONITORING (2012)
Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone
Makoto Ohnishi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Population Pharmacokinetics of Meropenem in Plasma and Cerebrospinal Fluid of Infants With Suspected or Complicated Intra-abdominal Infections
P. Brian Smith et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Extrapolation of Adult Data and Other Data in Pediatric Drug-Development Programs
Julia Dunne et al.
PEDIATRICS (2011)
Early and Adequate Antibiotic Therapy in the Treatment of Severe Sepsis and Septic Shock
John D. Dickinson et al.
Current Infectious Disease Reports (2011)
Registration Trials of Antibacterial Drugs for the Treatment of Nosocomial Pneumonia
Alfred Sorbello et al.
CLINICAL INFECTIOUS DISEASES (2010)
Recommended Design Features of Future Clinical Trials of Antibacterial Agents for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Brad Spellberg et al.
CLINICAL INFECTIOUS DISEASES (2010)
Safety and Efficacy of Intravenous Tigecycline in Subjects with Secondary Bacteremia: Pooled Results from 8 Phase III Clinical Trials
David Gardiner et al.
CLINICAL INFECTIOUS DISEASES (2010)
Pharmacokinetic-Pharmacodynamic Considerations in the Design of Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia Studies: Look before You Leap!
Paul G. Ambrose et al.
CLINICAL INFECTIOUS DISEASES (2010)
Increasing Resistance of Acinetobacter Species to Imipenem in United States Hospitals, 1999-2006
Marc S. Hoffmann et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Antimicrobial treatment and clinical outcome for infections with carbapenem-and multiply-resistant Acinetobacter baumannii around London
David M. Livermore et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System
Mark D. Adams et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea
Young Kyoung Park et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Nosocomial Outbreak of Infection With Pan-Drug-Resistant Acinetobacter baumannii in a Tertiary Care University Hospital
Raquel Valencia et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Epidemiology and Impact of Imipenem Resistance in Acinetobacter baumannii
Ebbing Lautenbach et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline
N. C. Gordon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Extreme Drug Resistance in Acinetobacter baumannii Infections in Intensive Care Units, South Korea
Young Kyoung Park et al.
EMERGING INFECTIOUS DISEASES (2009)
Use of Pharmacokinetics and Pharmacodynamics in a Failure Analysis of Community-Acquired Pneumonia: Implications for Future Clinical Trial Study Design
Paul G. Ambrose
CLINICAL INFECTIOUS DISEASES (2008)
Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia
Peter E. Pertel et al.
CLINICAL INFECTIOUS DISEASES (2008)
Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: Characteristics and outcome in a series of 28 patients
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
M. S. Oliveira et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae
Krasimir Vasilev et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections:: a review of the scientific evidence
Drosos E. Karageorgopoulos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials
Liat Vidal et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
High tigecycline resistance in multidrug-resistant Acinetobacter baumannii
Shiri Navon-Venezia et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Peer-reviewed publication of clinical trials completed for pediatric exclusivity
Daniel K. Benjamin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
Arland Kumar et al.
CRITICAL CARE MEDICINE (2006)
Inhibition of daptomycin by pulmonary surfactant: In vitro modeling and clinical impact
JA Silverman et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Pseudomonas aeruginosa bacteremia:: Risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome
CI Kang et al.
CLINICAL INFECTIOUS DISEASES (2003)
Combined endpoints: can we use them?
J Lubsen et al.
STATISTICS IN MEDICINE (2002)
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
R Herbrecht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
WT Hughes et al.
CLINICAL INFECTIOUS DISEASES (2002)
Impact of antibiotic resistance on clinical outcomes and the cost of care
MS Niederman
CRITICAL CARE MEDICINE (2001)
Share Paper
